Stock Events

Stock Events

Defence Therapeutics 

€0.33
0
+€0.01+4.13% Today

Statistics

Day High
0.33
Day Low
0.33
52W High
0.65
52W Low
0.29
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DTC.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for many of the same diseases Defence Therapeutics targets, including cancer immunotherapy.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb operates in similar therapeutic areas as Defence Therapeutics, especially in oncology and immune-oncology, making them direct competitors in the biopharmaceutical sector.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including vaccines and treatments for immune and inflammatory diseases, competing in the same space as Defence Therapeutics.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences, Inc. focuses on the discovery, development, and commercialization of medicines in areas of unmet medical need, including oncology, competing directly with Defence Therapeutics' cancer therapies.
AMGEN
AMGN
Mkt Cap187.56B
Amgen Inc. is a biotechnology company that develops innovative human therapeutics, with a strong focus on oncology and inflammatory diseases, areas that overlap with Defence Therapeutics' focus.
Novartis
NVS
Mkt Cap297.32B
Novartis AG is a global healthcare company that operates in the research, development, manufacturing, and marketing of a wide range of healthcare products, including those in oncology and immunology, directly competing with Defence Therapeutics.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG focuses on pharmaceuticals and diagnostics in oncology, immunology, and infectious diseases, areas that are in direct competition with Defence Therapeutics' research and product development.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong emphasis on oncology, respiratory, cardiovascular, and metabolic diseases, competing in the same therapeutic areas as Defence Therapeutics.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a broad healthcare company that develops and sells pharmaceuticals, medical devices, and consumer health products, with a pharmaceutical division that competes in oncology and immunology.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, including cancer and inflammatory diseases, competing with Defence Therapeutics.

About

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Sebastien Plouffe
Country
US
ISIN
CA24463V1013

Listings

STU
DE
DTC.STU
F
DE
DTC.F
CN
CA
DTC.CN
OTC Link
US
DTCFF

0 Comments

Share your thoughts

FAQ

What is Defence Therapeutics stock price today?▼
The current price of DTC.STU is €0.33 EUR — it has increased by +4.13% in the past 24 hours. Watch Defence Therapeutics stock price performance more closely on the chart.
What is Defence Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Defence Therapeutics stocks are traded under the ticker DTC.STU.
Is Defence Therapeutics stock price growing?▼
DTC.STU stock has risen by +1.84% compared to the previous week, the month change is a -12.86% fall, over the last year Defence Therapeutics has showed a -45.75% decrease.
In which sector is Defence Therapeutics located?▼
Defence Therapeutics operates in the Health Care sector.
When did Defence Therapeutics complete a stock split?▼
Defence Therapeutics has not had any recent stock splits.
Where is Defence Therapeutics headquartered?▼
Defence Therapeutics is headquartered in Montreal, US.